Hospital patients define medical errors much more broadly than the traditional clinical definitions of medical errors. The patient definition of medical errors includes communication problems, responsiveness and falls, according to a new study published in the January 2007 issue of the Joint Commission Journal on Quality and Patient Safety.

Jan. 19, 2007 - A staph germ circulating in and out of hospitals produces a poison that can kill pneumonia patients within 72 hours, researchers said on Thursday.

Staphylococcus aureus bacteria — or S. aureus — can pass one another the gene for the toxin and are apparently swapping it more often, the researchers report in Friday's issue of the journal Science.

The toxin, called Panton Valentine leukocidin, or PVL, can itself cause pneumonia and can kill healthy tissue.

Jan. 18, 2007 - “Do I really need to fill out that form again? Isn’t there a way I can just answer the few questions that are different?”

This is one of the most common complaints Michael Zaroukian, M.D., hears from his patients — at least when he’s wearing his ‘primary care physician’ hat.

Jan. 18, 2007 - Polymer Solutions Inc.’s team of scientists led the research and development activities that created an advanced polymer wound care bandage that stays moist for multiple days and is absolutely non-stick. The concept of this technology, TheraGauze, originated with Dr. Guy Levy, founder of Soluble Systems LLC, a Virginia company.

January 18, 2007 - General Electric Company (NYSE: GE) and Abbott (NYSE: ABT), a global leader in medical diagnostic instruments and tests, announced today that they have entered into a definitive agreement for GE to acquire Abbott’s primary in vitro diagnostics businesses and Abbott Point-of-Care diagnostics business (formerly known as i-STAT) for $8.13 billion in cash. Abbott’s Molecular Diagnostics and Diabetes Care businesses are not part of the transaction and will remain part of Abbott.

January 18, 2007 - (BUSINESS WIRE)--General Electric Company (NYSE: GE) and Abbott (NYSE: ABT), a global leader in medical diagnostic instruments and tests, announced today that they have entered into a definitive agreement for GE to acquire Abbott’s primary in vitro diagnostics businesses and Abbott Point-of-Care diagnostics business (formerly known as i-STAT) for $8.13 billion in cash. Abbott’s Molecular Diagnostics and Diabetes Care businesses are not part of the transaction and will remain part of Abbott.

Jan. 18, 2007 - “Do I really need to fill out that form again? Isn’t there a way I can just answer the two questions that are different?”

This is one of the most common questions Michael Zaroukian, M.D., hears from his patients — at least when he’s wearing his ‘primary care physician’ hat.

Dr. Zaroukian, who’s also an associate professor of medicine and chief medical information officer at Michigan State University, was a guest speaker Tuesday at the 9th annual Integrating the Heathcare Enterprise (IHE) Connectathon, held Jan. 15-19 in downtown Chicago.

January 18, 2007 - “Do I really need to fill out that form again?”

This is one of the most common complaints Michael Zaroukian, M.D., hears from his patients — at least when he’s wearing his ‘primary care physician hat.’

Dr. Zaroukian, who’s also an associate professor of medicine and chief medical information officer at Michigan State University, was a guest speaker Tuesday at the 9th annual Integrating the Heathcare Enterprise (IHE) Connectathon, held Jan. 15-19 in downtown Chicago.

Jan. 17, 2007 - The chairman of the Senate Judiciary Committee said on Wednesday he will introduce legislation to prevent drugmakers from striking deals that restrict the introduction of cheaper generic drugs.

The bill planned by Sen. Patrick Leahy, a Vermont Democrat, targets an increasingly common tactic used by brand-name drug makers — legal settlements that involve payments to generic rivals to restrict the sale of generic alternatives.

Leahy said the bill is supported by several other senators, including Republican Charles Grassley of Iowa.

Jan. 17, 2007 - Siemens Medical Solutions announced that as of January 1, 2007, it has taken control of Gesellschaft für Systemforschung und Dienstleistungen im Gesundheitswesen mbH (GSD), a health information systems (HIS) that Siemens acquired to strengthen its position in the healthcare information technology sector, especially in Germany and other European countries.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now